The 1 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 25.00, with a high estimate of 25.00 and a low estimate of� Peers & Competitors. Market cap, P/E ratio, Today's change, 1 year change, 1 year trend. BPTHBio Path Holdings Inc, $21.9M, NM, -3.54%, +255.21%. Get today's Bio Path Holdings Inc stock price and latest BPTH news as well as Bio Path real-time stock quotes, technical analysis, full financials and more. Real-time trade and investing ideas on Bio-Path Holdings Inc. BPTH from the largest community of traders and investors.
This study addresses two critical issues regarding the use of CNN for stock in the input by 2 along both the width and height, discarding 75% of the activation.
The 1 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 25.00, with a high estimate of 25.00 and a low estimate of� Peers & Competitors. Market cap, P/E ratio, Today's change, 1 year change, 1 year trend. BPTHBio Path Holdings Inc, $21.9M, NM, -3.54%, +255.21%. Get today's Bio Path Holdings Inc stock price and latest BPTH news as well as Bio Path real-time stock quotes, technical analysis, full financials and more. Real-time trade and investing ideas on Bio-Path Holdings Inc. BPTH from the largest community of traders and investors. Bio-Path Holdings, Inc. (BPTH) Company Bio. Bio-Path Holdings, Inc. focuses on developing therapeutic products utilizing its proprietary liposomal delivery� This study addresses two critical issues regarding the use of CNN for stock in the input by 2 along both the width and height, discarding 75% of the activation.
Get today's Bio Path Holdings Inc stock price and latest BPTH news as well as Bio Path real-time stock quotes, technical analysis, full financials and more.
Bio-Path Holdings, Inc. (BPTH) Company Bio. Bio-Path Holdings, Inc. focuses on developing therapeutic products utilizing its proprietary liposomal delivery� This study addresses two critical issues regarding the use of CNN for stock in the input by 2 along both the width and height, discarding 75% of the activation.
This study addresses two critical issues regarding the use of CNN for stock in the input by 2 along both the width and height, discarding 75% of the activation.
Real-time trade and investing ideas on Bio-Path Holdings Inc. BPTH from the largest community of traders and investors. Bio-Path Holdings, Inc. (BPTH) Company Bio. Bio-Path Holdings, Inc. focuses on developing therapeutic products utilizing its proprietary liposomal delivery�
Get today's Bio Path Holdings Inc stock price and latest BPTH news as well as Bio Path real-time stock quotes, technical analysis, full financials and more.
The 1 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 25.00, with a high estimate of 25.00 and a low estimate of� Peers & Competitors. Market cap, P/E ratio, Today's change, 1 year change, 1 year trend. BPTHBio Path Holdings Inc, $21.9M, NM, -3.54%, +255.21%. Get today's Bio Path Holdings Inc stock price and latest BPTH news as well as Bio Path real-time stock quotes, technical analysis, full financials and more. Real-time trade and investing ideas on Bio-Path Holdings Inc. BPTH from the largest community of traders and investors. Bio-Path Holdings, Inc. (BPTH) Company Bio. Bio-Path Holdings, Inc. focuses on developing therapeutic products utilizing its proprietary liposomal delivery� This study addresses two critical issues regarding the use of CNN for stock in the input by 2 along both the width and height, discarding 75% of the activation.